These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 27151080)
1. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Onesto E; Colombrita C; Gumina V; Borghi MO; Dusi S; Doretti A; Fagiolari G; Invernizzi F; Moggio M; Tiranti V; Silani V; Ratti A Acta Neuropathol Commun; 2016 May; 4(1):47. PubMed ID: 27151080 [TBL] [Abstract][Full Text] [Related]
2. Impairment of Mitochondrial Calcium Buffering Links Mutations in C9ORF72 and TARDBP in iPS-Derived Motor Neurons from Patients with ALS/FTD. Dafinca R; Barbagallo P; Farrimond L; Candalija A; Scaber J; Ababneh NA; Sathyaprakash C; Vowles J; Cowley SA; Talbot K Stem Cell Reports; 2020 May; 14(5):892-908. PubMed ID: 32330447 [TBL] [Abstract][Full Text] [Related]
3. TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. Wang P; Deng J; Dong J; Liu J; Bigio EH; Mesulam M; Wang T; Sun L; Wang L; Lee AY; McGee WA; Chen X; Fushimi K; Zhu L; Wu JY PLoS Genet; 2019 May; 15(5):e1007947. PubMed ID: 31100073 [TBL] [Abstract][Full Text] [Related]
4. Impairment of mitochondrial oxidative phosphorylation in skin fibroblasts of SALS and FALS patients is rescued by in vitro treatment with ROS scavengers. Debska-Vielhaber G; Miller I; Peeva V; Zuschratter W; Walczak J; Schreiber S; Petri S; Machts J; Vogt S; Szczepanowska J; Gellerich FN; Hermann A; Vielhaber S; Kunz WS Exp Neurol; 2021 May; 339():113620. PubMed ID: 33497646 [TBL] [Abstract][Full Text] [Related]
11. Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders. Janssens J; Van Broeckhoven C Hum Mol Genet; 2013 Oct; 22(R1):R77-87. PubMed ID: 23900071 [TBL] [Abstract][Full Text] [Related]
12. Disease-associated mutations of TDP-43 promote turnover of the protein through the proteasomal pathway. Araki W; Minegishi S; Motoki K; Kume H; Hohjoh H; Araki YM; Tamaoka A Mol Neurobiol; 2014 Dec; 50(3):1049-58. PubMed ID: 24477737 [TBL] [Abstract][Full Text] [Related]
13. Reduced stress granule formation and cell death in fibroblasts with the A382T mutation of TARDBP gene: evidence for loss of TDP-43 nuclear function. Orrù S; Coni P; Floris A; Littera R; Carcassi C; Sogos V; Brancia C Hum Mol Genet; 2016 Oct; 25(20):4473-4483. PubMed ID: 28172957 [TBL] [Abstract][Full Text] [Related]
14. Clinical and neuropathological features of ALS/FTD with TIA1 mutations. Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908 [TBL] [Abstract][Full Text] [Related]
15. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways. Blokhuis AM; Koppers M; Groen EJN; van den Heuvel DMA; Dini Modigliani S; Anink JJ; Fumoto K; van Diggelen F; Snelting A; Sodaar P; Verheijen BM; Demmers JAA; Veldink JH; Aronica E; Bozzoni I; den Hertog J; van den Berg LH; Pasterkamp RJ Acta Neuropathol; 2016 Aug; 132(2):175-196. PubMed ID: 27164932 [TBL] [Abstract][Full Text] [Related]
16. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other? Baloh RH Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957 [TBL] [Abstract][Full Text] [Related]
17. Chronic stress induces formation of stress granules and pathological TDP-43 aggregates in human ALS fibroblasts and iPSC-motoneurons. Ratti A; Gumina V; Lenzi P; Bossolasco P; Fulceri F; Volpe C; Bardelli D; Pregnolato F; Maraschi A; Fornai F; Silani V; Colombrita C Neurobiol Dis; 2020 Nov; 145():105051. PubMed ID: 32827688 [TBL] [Abstract][Full Text] [Related]
18. Primary fibroblasts derived from sporadic amyotrophic lateral sclerosis patients do not show ALS cytological lesions. Codron P; Cassereau J; Vourc'h P; Veyrat-Durebex C; Blasco H; Kane S; Procaccio V; Letournel F; Verny C; Lenears G; Reynier P; Chevrollier A Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):446-456. PubMed ID: 29382228 [TBL] [Abstract][Full Text] [Related]
19. Primary fibroblasts cultures reveal TDP-43 abnormalities in amyotrophic lateral sclerosis patients with and without SOD1 mutations. Sabatelli M; Zollino M; Conte A; Del Grande A; Marangi G; Lucchini M; Mirabella M; Romano A; Piacentini R; Bisogni G; Lattante S; Luigetti M; Rossini PM; Moncada A Neurobiol Aging; 2015 May; 36(5):2005.e5-2005.e13. PubMed ID: 25792239 [TBL] [Abstract][Full Text] [Related]
20. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology. Ince PG; Highley JR; Kirby J; Wharton SB; Takahashi H; Strong MJ; Shaw PJ Acta Neuropathol; 2011 Dec; 122(6):657-71. PubMed ID: 22105541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]